News articles about CIGNA (NYSE:CI) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. CIGNA earned a news sentiment score of 0.22 on Accern’s scale. Accern also assigned media coverage about the health services provider an impact score of 45.5308328011021 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the headlines that may have effected Accern Sentiment’s rankings:
- Cigna Kicks Off Year’s Second Biggest Bond Sale: Smith (Radio) (bloomberg.com)
- BlueCross of Tennessee will stop covering OxyContin in 2019 (marketbeat.com)
- CVS-Aetna And Cigna-Express Scripts Deals About To Get Green Light From Antitrust Enforcers, Sources Say (khn.org)
- DOJ nearing antitrust approval of Express Scripts’ sale to Cigna (msn.com)
- [$$] Justice Department Nearing Antitrust Approval of Health Mergers (finance.yahoo.com)
CI opened at $185.18 on Friday. CIGNA has a 52 week low of $163.02 and a 52 week high of $227.13. The stock has a market cap of $45.84 billion, a price-to-earnings ratio of 17.70, a P/E/G ratio of 1.11 and a beta of 0.63. The company has a quick ratio of 0.38, a current ratio of 0.38 and a debt-to-equity ratio of 0.35.
CIGNA (NYSE:CI) last released its quarterly earnings data on Thursday, August 2nd. The health services provider reported $3.89 EPS for the quarter, beating the consensus estimate of $3.33 by $0.56. CIGNA had a net margin of 5.82% and a return on equity of 22.27%. The business had revenue of $11.50 billion during the quarter, compared to the consensus estimate of $11.20 billion. During the same quarter in the prior year, the firm earned $2.91 EPS. The business’s revenue was up 10.9% on a year-over-year basis. sell-side analysts forecast that CIGNA will post 13.87 EPS for the current fiscal year.
A number of equities research analysts have issued reports on the company. SunTrust Banks increased their price target on CIGNA to $244.00 and gave the stock a “buy” rating in a research note on Friday, August 3rd. Jefferies Financial Group reiterated a “buy” rating and issued a $224.00 price target on shares of CIGNA in a research note on Friday, August 3rd. ValuEngine upgraded CIGNA from a “sell” rating to a “hold” rating in a research note on Friday, August 3rd. Zacks Investment Research upgraded CIGNA from a “hold” rating to a “buy” rating and set a $212.00 price target for the company in a research note on Tuesday, August 7th. Finally, Goldman Sachs Group upgraded CIGNA from a “neutral” rating to a “buy” rating and increased their price target for the stock from $193.00 to $212.00 in a research note on Wednesday, June 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $221.77.
In other CIGNA news, Director William D. Zollars sold 265 shares of the stock in a transaction dated Thursday, June 14th. The shares were sold at an average price of $176.93, for a total transaction of $46,886.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Eric P. Palmer acquired 2,828 shares of the company’s stock in a transaction on Tuesday, July 31st. The shares were bought at an average cost of $177.61 per share, with a total value of $502,281.08. Following the acquisition, the chief financial officer now directly owns 9,678 shares in the company, valued at $1,718,909.58. The disclosure for this purchase can be found here. 1.10% of the stock is owned by corporate insiders.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Read More: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.